AI tutors migraine patients in new swiss trial

NCT ID NCT06507150

Recruiting now Knowledge-focused Sponsor: Ente Ospedaliero Cantonale, Bellinzona Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether adding AI-powered education to standard migraine education helps people newly diagnosed with migraine understand their condition better. 140 adults aged 18-65 will be split into two groups: one gets standard education alone, the other gets standard education plus AI-assisted lessons. The main goal is to see if the AI group scores higher on a 20-question migraine knowledge test after 3 months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: AI-assisted migraine education (AIME)
What this could lead to: If it works, this could show that AI tools can improve patient understanding of migraine, leading to better self-management and fewer misdiagnoses.
What could go wrong: This is a small, early-stage study (140 people) testing education, not a treatment. The benefit may be small or not last beyond 6 months.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MIGRAINE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

migraine disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MIGRAINE

Contacts and locations

Locations

Ente Ospedaliero Cantonale - Ospedale Regionale di Lugano
RECRUITING

Lugano, Switzerland

More trials for these conditions

Other studies related to the condition(s) this trial covers.